Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 12:12:833894.
doi: 10.3389/fonc.2022.833894. eCollection 2022.

Radiosensitivity of Breast Cancer Cells Is Dependent on the Organ Microenvironment

Affiliations

Radiosensitivity of Breast Cancer Cells Is Dependent on the Organ Microenvironment

Genyan Guo et al. Front Oncol. .

Abstract

Background: Distant metastasis is the leading risk factor of death in breast cancer patients, with lung and liver being commonly involved sites of distant seeding. Ongoing clinical trials are studying the benefit from additional local treatment to these metastatic sites with radiation therapy. However, little is known about the tissue-specific microenvironment and the modulating response to treatments due to limitations of traditional in vitro systems. By using biomatrix scaffolds (BMSs) to recreate the complex composition of extracellular matrices in normal organs, we chose to study the radiotherapy response with engineered breast cancer "metastases" in liver and lung organ-specific tissues.

Methods: Liver and lung BMSs were prepared for tissue culture. Human breast cancer cell lines were passaged on normal tissue culture plates or tissue culture plates coated with Matrigel, liver BMSs, and lung BMSs. Clonogenic assays were performed to measure cell survival with varying doses of radiation. Reactive Oxygen Species (ROS) detection assay was used to measure ROS levels after 6 Gy irradiation to cancer cells.

Results: The response of breast cell lines to varying doses of radiotherapy is affected by their in vitro acellular microenvironment. Breast cancer cells grown in liver BMSs were more radiosensitive than when grown in lung BMSs. ROS levels for breast cancer cells cultured in lung and liver BMSs were higher than that in plastic or in Matrigel plate cells, before and after radiotherapy, highlighting the interaction with surrounding tissue-specific growth factors and cytokines. ROSs in both lung and liver BMSs were significantly increased after radiotherapy delivery, suggesting these sites create prime environments for radiation-induced cell death.

Conclusions: The therapeutic response of breast cancer metastases is dependent on the organ-specific microenvironment. The interaction between tissue microenvironment in these organs may identify sensitivity of therapeutic drug targets and radiation delivery for future studies.

Keywords: biomatrix scaffolds; breast cancer; decellularized; engineer metastases; radiation response; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Decellularization of lung (A) and liver (B) tissues produces BMSs containing tissue specific signaling molecules.
Figure 2
Figure 2
Three-dimensional cell colonies BT20 in (A) Matrigel, (B) lung, (C) liver.
Figure 3
Figure 3
Three-dimensional cell colonies BT549 in (A) Matrigel, (B) lung, (C) liver.
Figure 4
Figure 4
Breast cancer cells grown on different substrata respond differently to radiotherapy. Response of breast cancer cells grown on plastic, Matrigel, liver BMSs, and lung BMSs to radiotherapy (n = 3 biologically independent cell samples). Data represent mean ± S.E.M.
Figure 5
Figure 5
ROS were measured with DCF-DA staining with BT-20 and BT-549 breast cancer cell lines before (A, D) and after radiotherapy delivery (B, E). The relative increases in ROS can be found in (C, F). Data represent mean ± S.E.M. * denotes P<0.05, ** denotes P<0.001.

Similar articles

Cited by

References

    1. Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA (2019) 321(3):288–300. doi: 10.1001/jama.2018.19323 - DOI - PubMed
    1. Kimbung S, Loman N, Hedenfalk I. Clinical and Molecular Complexity of Breast Cancer Metastases. Semin Cancer Biol (2015) 35:85–95. doi: 10.1016/j.semcancer.2015.08.009 - DOI - PubMed
    1. Foster CC, Pitroda SP, Weichselbaum RR. Definition, Biology, and History of Oligometastatic and Oligoprogressive Disease. Cancer J (2020) 26(2):96–9. doi: 10.1097/PPO.0000000000000434 - DOI - PubMed
    1. Olson R, Mathews L, Liu M, Schellenberg D, Mou B, Berrang T, et al. . Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 1-3 Oligometastatic Tumors (SABR-COMET-3): Study Protocol for a Randomized Phase III Trial. BMC Cancer (2020) 20(1):380. doi: 10.1186/s12885-020-06876-4 - DOI - PMC - PubMed
    1. Crapo PM, Gilbert TW, Badylak SF. An Overview of Tissue and Whole Organ Decellularization Processes. Biomaterials (2011) 32(12):3233–43. doi: 10.1016/j.biomaterials.2011.01.057 - DOI - PMC - PubMed

LinkOut - more resources